Trending Down-0.1400 (-1.0294%)
  • Bid / Lots
    13.2000/ 7
  • Ask / Lots
    15.0000/ 1
  • Open / Previous Close
    13.5000 / 13.6000
  • Day Range
    Low 13.0501
    High 13.9000
  • 52 Week Range
    Low 5.2000
    High 14.6000
  • Volume
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 13.6
09:32 ET106113.5
09:36 ET332313.9
09:39 ET50213.5
09:45 ET1167213.5
09:50 ET590013.17
09:52 ET93213.17
09:54 ET60013.44
10:03 ET390013.19
10:06 ET10013.19
10:08 ET30013.0501
10:10 ET480013.115
10:12 ET230013.18
10:14 ET644913.2
10:15 ET10013.21
10:24 ET33513.3
10:53 ET30013.215
10:55 ET20013.22
11:02 ET10013.305
11:40 ET10013.305
11:42 ET10013.23
11:44 ET16613.305
11:45 ET35013.3
11:49 ET30013.3
11:54 ET26513.4
11:56 ET60013.31
12:02 ET50013.36
12:05 ET30013.49
12:07 ET70013.49
12:12 ET30013.49
12:18 ET25013.5
12:21 ET75013.34
12:23 ET10013.42
12:30 ET10013.42
12:32 ET10013.46
12:34 ET30013.35
12:36 ET40013.35
12:41 ET10013.42
12:45 ET10013.42
01:03 ET10013.48
01:44 ET10013.46
01:53 ET10013.48
02:00 ET170013.25
02:06 ET30013.31
02:20 ET20013.365
02:54 ET10013.31
03:03 ET42213.3
03:05 ET80013.34
03:07 ET10013.25
03:12 ET90013.2101
03:14 ET20013.2101
03:16 ET20013.21
03:18 ET20013.23
03:20 ET10013.21
03:21 ET60013.2
03:25 ET60013.2
03:32 ET60013.2001
03:36 ET20013.22
03:38 ET20013.24
03:39 ET20013.25
03:41 ET50013.24
03:45 ET70013.21
03:48 ET10513.2128
03:50 ET50013.21
03:52 ET103313.2
03:54 ET101513.4886
03:59 ET77413.46
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesALVO
Alvotech SA
United StatesCYTK
Cytokinetics Inc
United StatesCERE
Cerevel Therapeutics Holdings Inc
United StatesNTLA
Intellia Therapeutics Inc
United StatesCRSP
CRISPR Therapeutics AG
United StatesDNLI
Denali Therapeutics Inc
As of 2023-03-25

Company Information

Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Contact Information

9, Rue De BitbourgLUXEMBOURG, Luxembourg 1273


Executive Chairman of the Board, Founder
Robert Wessman
Chief Executive Officer
Mark Levick
Deputy Chief Executive Officer
Tanya Zharov
Independent Deputy Chairman of the Board
Richard Davies
Chief Financial Officer
Joel Morales

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.